PATENT CLAIM ANALYSIS

Application Number: 15889857
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "023000"]

Abstract:
Disclosed herein are compositions containing an opioid antagonist such as naloxone and one or more pharmaceutically acceptable excipients. The compositions may be used for intranasal delivery of Naloxone for the treatment of, for example, opioid overdose in an individual in need thereof. Also disclosed are methods of making compositions containing Naloxone, and devices for nasal delivery of naloxone compositions.

Claim (Index 12):
A method of treating an opioid overdose in an individual in need thereof, the method comprising nasally administering to the individual a therapeutically effective amount of the nasal spray composition of  claim 1  to treat the opioid overdose.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 88.0
- Lexical Diversity: 1.51163
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14882857', '14576357', '14950707', '14942344', '14659472']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8140643234216567
- 35 USC 102 Novelty (BERT): 0.5769194389135895
- Combined Prediction Score: 0.79034983497085
- Mean Citation Score: 452.678166
- Max Citation Score: 531.403
- Similarity Product: 387.4052518935204

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test